We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

Stryker reported $6.4 billion in sales and $22,595 million in operating profit for the quarter ending December 31, 2024, ...

Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...

Inari Medical, Inc. NARI is well-poised for ... private insurers and other payors for a particular procedure, irrespective of the devices used. Meanwhile, third-party payors are increasingly ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In addition to the Inari Medical deal, Stryker has also acquired Vertos Medical, a company specializing in minimally invasive procedures for treating lumbar spinal stenosis. This move strengthens ...